Back to Journals » Cancer Management and Research
Cancer Management and Research
ISSN: 1179-1322
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4645)
- Volume 16, 2024 (51)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Predictive Value of the Total Bilirubin and CA50 Screened Based on Machine Learning for Recurrence of Bladder Cancer Patients
Zhang X, Ma L
Cancer Management and Research 2024, 16:537-546
Published Date: 31 May 2024
Machine Learning for Prediction of Non-Small Cell Lung Cancer Based on Inflammatory and Nutritional Indicators in Adults: A Cross-Sectional Study
Wang Q, Liang T, Li Y, Liu X
Cancer Management and Research 2024, 16:527-535
Published Date: 30 May 2024
Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway
Bae S, Bae S, Kim HS, Lim YJ, Kim G, Park IC, So KA, Kim TJ, Lee JH
Cancer Management and Research 2024, 16:507-525
Published Date: 28 May 2024
Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer
Zhou JY, Pan CG, Ye Y, Li ZW, Fu WD, Jiang BH
Cancer Management and Research 2024, 16:491-505
Published Date: 21 May 2024
Anticancer Effects of Wild Baicalin on Hepatocellular Carcinoma: Downregulation of AKR1B10 and PI3K/AKT Signaling Pathways
Sun L, Chen W, Zhao P, Zhao B, Lei G, Han L, Zhang Y
Cancer Management and Research 2024, 16:477-489
Published Date: 21 May 2024